External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study

SIMPLE SUMMARY: We externally validated the recently suggested FSAC prediction model for hepatocellular carcinoma (HCC) in treatment-naïve Asian chronic hepatitis B patients starting potent antiviral therapy (AVT). The model reflects age, sex, presence of cirrhosis, and on-therapy changes in non-inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Seung, Lee, Hyun Woong, Lim, Tae Seop, Min, In Kyung, Lee, Hye Won, Kim, Seung Up, Park, Jun Yong, Kim, Do Young, Ahn, Sang Hoon, Kim, Beom Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833581/
https://www.ncbi.nlm.nih.gov/pubmed/35158982
http://dx.doi.org/10.3390/cancers14030711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833581/
https://www.ncbi.nlm.nih.gov/pubmed/35158982
http://dx.doi.org/10.3390/cancers14030711

Ejemplares similares